Streetbeat News

Analyst Ratings

BXP

Barclays analyst Anthony Powell has maintained an Equal-Weight rating on Boston Properties (NYSE:BXP) but has reduced the price target from $65 to $64.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:35 am

SNCE

Baird analyst Eric Coldwell has downgraded Science 37 Holdings (NASDAQ:SNCE) from Outperform to Neutral and set a price target of $5.75.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:32 am

ALV

Barclays analyst Dan Levy has maintained an Equal-Weight rating on Autoliv (NYSE:ALV) and increased the price target from $105 to $107.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:31 am

MASI

Jefferies analyst Matthew Taylor has downgraded Masimo (NASDAQ:MASI) from Buy to Hold while increasing the price target from $107 to $121. This reflects a more cautious stance on the stock's current valuation, despite the raised target suggesting some potential for upside.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:30 am

ST

Oppenheimer analyst Christopher Glynn has upgraded Sensata Technologies (NYSE:ST) from Perform to Outperform and set a price target of $50. This upgrade reflects a positive outlook on the company's performance and potential growth.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:28 am

SPOT

UBS analyst Batya Levi has upgraded Spotify Technology (NYSE:SPOT) from Neutral to Buy and increased the price target from $170 to $274.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:26 am

STEL

Raymond James analyst David Feaster has maintained an Outperform rating on Stellar Bancorp (NYSE:STEL) and increased the price target from $24 to $29.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:22 am

DX

JonesTrading analyst Jason Stewart has reaffirmed a Buy rating on Dynex Capital (NYSE:DX) and increased the price target from $13 to $14. The report was released on January 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:19 am

MMSI

Raymond James analyst Jayson Bedford has maintained an Outperform rating on Merit Medical Systems (NASDAQ:MMSI) and increased the price target from $84 to $89.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:19 am

DX

JonesTrading analyst Jason Stewart has reiterated a Buy rating on Dynex Cap (NYSE:DX) and increased the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:19 am